J Microbiol Immunol Infect . Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2

[tetano]

J Microbiol Immunol Infect


. 2020 Aug 6;S1684-1182(20)30174-2.
doi: 10.1016/j.jmii.2020.07.017. Online ahead of print.
Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2


Fang Liu ¹ , Zhao-Bin Cai ² , Jin-Song Huang ² , Hai-Ying Niu ¹ , Wen-Yan Yu ¹ , Yan Zhang ¹ , Ting-Bo Yan ³ , Chen Chen ⁴ , Yuan Liu ¹ , Ai-Fang Xu ⁵



Affiliations

• PMID: 32807688
• DOI: 10.1016/j.jmii.2020.07.017

Abstract

A case who revealed the longest duration of viral shedding (67 days) in current reports, presented complicated characteristic on the relapse of COVID-19 due to the inconsistent performance of chest radiography and SARS-CoV-2-RNA detection after discharge. Lopinavir-interferon α2b boosted ribavirin following with lopinavir boosted budesonide might be a potent treatment for viral clearance.

Keywords: Coronavirus disease 2019; Prognosis; Recovered patients; SARS-CoV-2 re-positive; Viral shedding.